Regulation - Pricing, Tafinlar

Filter

Current filters:

PricingTafinlar

Popular Filters

IQWiG says added benefit of GSK’s Tafinlar not proven

IQWiG says added benefit of GSK’s Tafinlar not proven

07-01-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

GermanyGlaxoSmithKlineNorthern EuropeOncologyPharmaceuticalPricingRegulationTafinlar

Company Spotlight

ImmunoGen

ImmunoGen

Back to top